Literature DB >> 3518917

Association of antigen expression and DNA ploidy in human colorectal tumors.

L G Durrant, R A Robins, N C Armitage, A Brown, R W Baldwin, J D Hardcastle.   

Abstract

Fifty colorectal tumors were screened by indirect immunofluorescence and flow cytometry for antigen expression using a panel of monoclonal antibodies that recognize determinants preferentially expressed on tumor cells (carcinoembryonic antigen, Y haptenic blood group, 791T/36 defined antigen 791T-P72). Fifty % of the tumors expressed all three antigens, 41%, two, and 9%, one. Over a third reacted strongly with at least one monoclonal antibody, although the majority of tumors stained with a moderate intensity. Extranuclear membranes from tumors showed similar antigen expression to disaggregated tumor cells and were particularly useful for providing the relative tumor:normal tissue binding ratios. The carcinoembryonic antigen specific monoclonal antibody showed the strongest tumor selectivity with a tumor:normal tissue ratio of 24 +/- 7:1. Lack of correlation between expression of the three antigens suggested that the monoclonal antibodies recognizing them may have potential as a "cocktail." One-third of the tumors contained cells with an aneuploid DNA content and expressed elevated levels of carcinoembryonic antigen and Y haptenic blood group antigen when compared to tumors with diploid DNA content. Aneuploid cells within a tumor were also preferentially stained with all of the monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3518917

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.

Authors:  L G Durrant; V S Byers; P J Scannon; R Rodvien; K Grant; R A Robins; R A Marksman; R W Baldwin
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

2.  Prognostic significance of DNA content abnormalities in young patients with colorectal cancer.

Authors:  T M Heimann; G Martinelli; A Szporn; R J Kurtz; A Quish; F Miller; S C Oh; T Fasy
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

3.  Mapping of monoclonal antibody-defined epitopes associated with carcinoembryonic antigen, CEA.

Authors:  M R Price; S Edwards; E Jacobs; I Z Pawluczyk; V S Byers; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Epitopes of carcinoembryonic antigen (CEA) defined by monoclonal antibodies.

Authors:  M R Price
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

5.  Development of an ELISA to detect early local relapse of colorectal cancer.

Authors:  L G Durrant; H Jones; N C Armitage; R W Baldwin
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

6.  Patterns of reactivity of the monoclonal antibody 791T/36 with different tumour metastases in the liver.

Authors:  C J Hawkey; C H Holmes; P G Smith; E B Austin; R W Baldwin
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

7.  Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.

Authors:  L G Durrant; R A Robins; K C Ballantyne; R A Marksman; J D Hardcastle; R W Baldwin
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

8.  Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.

Authors:  L G Durrant; M C Garnett; J Gallego; N C Armitage; K C Ballantyne; R A Marksman; J D Hardcastle; R W Baldwin
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

9.  Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression.

Authors:  L G Durrant; K C Ballantyne; N C Armitage; R A Robins; R Marksman; J D Hardcastle; R W Baldwin
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.